Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing (original) (raw)

Quetiapine: An Objective Evaluation of Pharmacology,Clinical Uses and Intoxication

Ramadhan Oruch

2020

View PDFchevron_right

Introduction. Quetiapine: A 5-Year Update

jeffrey lieberman

The Journal of Clinical Psychiatry, 2002

View PDFchevron_right

Quetiapine in the treatment of schizophrenia and related disorders

Emanuel Severus

Neuropsychiatric Disease and Treatment, 2007

View PDFchevron_right

Quetiapine – efficacy in different domains

Tonmoy Sharma

European Neuropsychopharmacology, 2001

View PDFchevron_right

Quetiapine, an Atypical Antipsychotic

Jessica Goren

1998

View PDFchevron_right

Quetiapine: efficacy and tolerability in schizophrenia

Angela Heiden

European Neuropsychopharmacology, 2001

View PDFchevron_right

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial

Emmanuel Stip

Current Medical Research and Opinion, 2006

View PDFchevron_right

Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders

Emmanuel Stip

International Clinical Psychopharmacology, 2011

View PDFchevron_right

Quetiapine versus typical antipsychotic medications for schizophrenia

Siritree Suttajit

The Cochrane …, 2009

View PDFchevron_right

Misuse and abuse of quetiapine

Bogusław Habrat

Psychiatria Polska, 2015

View PDFchevron_right

Antipsychotic Effects of Quetiapine in Naturalistic Long Term Follow Up Study

Se Lim

Psychiatry Investigation, 2010

View PDFchevron_right

Therapeutic Drug Monitoring of Quetiapine: Effect of Coadministration with Antiepileptic Drugs in Patients with Psychiatric Disorders

Maria Rosaria Anna Muscatello

The Open Clinical Chemistry Journal, 2008

View PDFchevron_right

Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas

tanja veselinovic

The International Journal of Neuropsychopharmacology, 2010

View PDFchevron_right

The Role of Quetiapinein the Treatment of Alzheimer's Disease

Pietro Gareri

Journal of Gerontology & Geriatric Research, 2015

View PDFchevron_right

Quetiapine and the Need for a Thorough QT/QTc Study

Ericka Crouse

Journal of Clinical Psychopharmacology, 2014

View PDFchevron_right

Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study

José Calderón

Clinical Drug Investigation, 2016

View PDFchevron_right

Spotlight on Quetiapine in Bipolar Depression1

Dean Robinson

CNS Drugs, 2007

View PDFchevron_right

HPLC analysis of the novel antipsychotic drug quetiapine in human plasma

Roberto Mandrioli

Journal of Pharmaceutical and Biomedical Analysis, 2002

View PDFchevron_right

Quetiapine Abuse Fourteen Years Later: Where Are We Now? A Systematic Review

Georgios Kotzalidis

Substance Use & Misuse, 2019

View PDFchevron_right

Quetiapine at high doses for the treatment of refractory schizophrenia

Douglas Boggs

Schizophrenia Research, 2008

View PDFchevron_right

Neuropharmacological Profile of a Novel Potential Atypical Antipsychotic Drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate)

Masatake Fujimura

Neuropsychopharmacology, 2002

View PDFchevron_right

Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literature

Todd Zorick

Drug and Alcohol Review, 2010

View PDFchevron_right

Comparative bioavailability of two different quetiapine doses (50 and 200 mg) in healthy volunteers by using LC/MS method

Tawfiq Arafat

View PDFchevron_right

Pharmacokinetics of Quetiapine in Elderly Patients with Selected Psychotic Disorders

George Jaskiw

Clinical Pharmacokinetics, 2004

View PDFchevron_right

Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study

Doron Mazeh

International Journal of Geriatric Psychiatry, 2008

View PDFchevron_right